Showing 9341-9350 of 19228 results for "".
- Innovation in Pancreatic Cancer Care: UT Health San Antonio's Breakthrough with Radiofrequency Ablationhttps://reachmd.com/news/innovation-in-pancreatic-cancer-care-ut-health-san-antonios-breakthrough-with-radiofrequency-ablation/2484938/UT Health San Antonio performed the first regional endoscopic radiofrequency ablation (RFA) for an inoperable pancreatic cancer pat
- Unraveling the Impact of GDF3 Signaling in Age-Related Inflammationhttps://reachmd.com/news/unraveling-the-impact-of-gdf3-signaling-in-age-related-inflammation/2484949/University of Minnesota researchers show that macrophage-derived GDF3 sustains low-grade inflammation in older adults and increases vulnerability to infection, linking aged immune cell
- Unlocking the Immune Code: Advances in Lichen Planus Pathogenesis and Emerging Therapieshttps://reachmd.com/news/unlocking-the-immune-code-advances-in-lichen-planus-pathogenesis-and-emerging-therapies/2484954/Once considered a relatively obscure dermatologic condition, lichen planus (LP) is gaining renewed scientific interest thanks to
- Most Insurers Cover Botulinum Toxin for Axillary Hyperhidrosis: Analysishttps://reachmd.com/news/most-insurers-cover-botulinum-toxin-for-axillary-hyperhidrosis-analysis/2484933/A new cross-sectional study published in the Journal of Drugs in Dermatology finds that while botulinum toxin is broadly covered by private insurers for the treatment of primary axillary hyperhidrosis, access barriers due to
- Evaluating Targeted Therapies for Inflammatory Skin Diseases: A Focus on Baricitinib in Lichen Planushttps://reachmd.com/news/evaluating-targeted-therapies-for-inflammatory-skin-diseases-a-focus-on-baricitinib-in-lichen-planus/2484952/Mayo Clinic investigators show that baricitinib produces rapid clinical benefit in liche
- Decoding Fetal Microcephaly: Genetic Insights from a Recent Prenatal Cohort Studyhttps://reachmd.com/news/fetal-microcephaly-genetic-prenatal-cohort/2484924/In a prenatal cohort, researchers found marked genotypic and phenotypic heterogeneity among fetuses with clinically identified microcephaly. In 197 fetuses referred fo
- Reframing MASLD: Oxygen-Nutrient Imbalance as a Key Driver of Diseasehttps://reachmd.com/news/masld-oxygen-nutrient-imbalance/2484916/In a new review, researchers reframe metabolic dysfunction-associated steatotic liver disease (MASLD) as a supply-demand injury in which excess portal caloric delivery can outpace hepatic oxyge
- Neonatal Outcomes in Preterm Infants by Gestational Age: Insights from a Retrospective Cohort Studyhttps://reachmd.com/news/neonatal-outcomes-preterm-infants-gestational-age/2484917/A recent cohort study provides new data on short-term neonatal outcomes across late‑preterm, early‑term, and full‑term births, quantifying risks that inform timing of elective delivery.
- Regulatory Milestones for the Holly Implantable Dialysis System: A New Era in Renal Replacement Technologyhttps://reachmd.com/news/holly-implantable-dialysis-renal-replacement/2484925/The Holly implantable dialysis system has received FDA Breakthrough Device de
- AAFPRS Issues Alert Regarding Rise of Counterfeit Neuromodulatorshttps://reachmd.com/news/aafprs-issues-alert-regarding-rise-of-counterfeit-neuromodulators/2484932/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released a warning to consumers to remain vigilant as counterfeit and unapproved neuromodulators continue to enter the aesthetic medicine market. The AAFPRS issued the warning after the US Food and Drug Administration